It also includes the determination of sarcopenia in the flow chart for nutritional therapy, and provides a nutritional guidance policy for LC patients with or without (1) a serum albumin level of 3.5 g/dL or less, (2) a Child-Pugh classification of B or C or (3) sarcopenia. This evidence concerns the gene ALB and laryngotracheoesophageal cleft.